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Abstract. Our previous report (Muir, D., S. Varon,
and M. Manthorpe. 1990. J. Cell Biol. 109:2663-
2672) described the isolation and partial characteriza-
tion of a 55-kD antiproliferative protein found in
Schwann cell (SC) and schwannoma cell line-con-
ditioned media and we concluded that SC proliferation
is under negative autocrine control . In the present
study the 55-kD protein was found to possess metallo-
protease activity and stromelysin immunoreactivity.
The SC-derived metalloprotease shares many proper-
ties with stromelysin isolated from other sources in-
cluding the ability to cleave fibronectin (FN). Further-
more, limited proteolysis of FN by the SC-derived
protease generated a FN fragment which itself expresses
a potent antiproliferative activity for SCs. The active
FN fragment corresponds to the 29-kD amino-terminal
region of the FN molecule which was also identified
as an active component in SC CM . Additional evidence
S
CHWANN cell (SC)' proliferation is highly regulated
and essentially occurs only during development and re-
generation. During development, SCs recognize and
adhere to axons and then are stimulated to proliferate and
eventually populate the entire length of the axon (Webster
and Favilla, 1984) . In healthy adult peripheral nerve, SCs
generally do not proliferate but they apparently can reenter
the mitotic cycle during Wallerian degeneration induced by
nerve trauma. These same SC behaviors can be reproduced
in vitro in that cultured SCs contact and adhere to neuronal
processes and then proliferate in response to a neuritic mito-
genic signal (Salzer and Bunge, 1980) . As in mature nerve,
SCs in established co-cultures eventually cease to proliferate
even in the continued presence ofpotentially mitogenic neu-
rons. Isolated SCs divide infrequently under standard cul-
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that a proteolytic fragment of FN can possess antipro-
liferative activity for SCs was provided by the finding
that plasmin can generate an amino-terminal FN frag-
ment which mimicked the activity of the SC metallo-
protease-generated antiproliferative FN fragment. Both
the 55-kD SC metalloprotease and the 29-kD FN frag-
ment could completely and reversibly inhibit prolif-
eration of SCs treated with various mitogens and both
were largely ineffective at inhibiting proliferation by
immortalized or transformed SC lines. Normal and
transformed SC types do secrete the proform of stro-
melysin, however, transformed cultures do not produce
activated stromelysin and thus cannot generate the an-
tiproliferative fragment of FN. These results suggest
that, once activated, a SC-derived protease similar to
stromelysin cleaves FN and generates an antiprolifera-
tive activity which can maintain normal SC quiescence
in vitro.
ture conditions and we have demonstrated that SCs release
a factor(s) into their culture medium which inhibits prolif-
eration in an autocrine manner (Muir et al., 1990x). From
conditioned medium (CM) a 55-kD protein was isolated and
partially characterized that completely and reversibly inhib-
its proliferation by SCs treated with a variety of mitogens in-
cluding that presented by regenerating neurons in co-culture.
Several molecular forms of antiproliferative activity were
found in SC CM. The 55-kD "Neural Antiproliferative Pro-
tein;" orNAP, exists in a free form and can be separated from
a high molecular mass complex. In addition, a lower mass
form (=30 kD) of antiproliferative activity was found in
SC CM.
Several characteristics of the antiproliferative activities
and specifically those of the 55-kD NAP suggested thepossi-
bility that proteolytic activation might be involved in the in-
hibition of SC proliferation. The present study tested the hy-
pothesis that a SC-derived protease can cleave and activate
a substrate in the culture medium which possesses a cryptic
antiproliferative activity for SCs. Results showed the 55-kD
NAP is immunologically related to and shares metal-
loprotease activity with stromelysin. We now can attribute
the previously described SC CM-derived =30-kD form of
antiproliferative activity to a 29-kD amino-terminal, heparin-
177binding FN fragment proteolytically generated by the SC-
derived metalloprotease. Preparations ofthis "Cryptic Anti-
proliferative Fibronectin Fragments or CAFF, were obtained
by incubating the 55-kD NAP with FN purified from the
plasma of several species. A plasmin-generated FN frag-
ment, with similar molecular characteristics to CAFF and
which was previously reported to inhibit the proliferation
of endothelial cells (Homandberg et al ., 1985, 1986), was
also generated and it too expressed antiproliferative activity
for SCs.
Materials andMethods
CellCulture
Purified populations ofquiescent SCs were obtained from dissociated neo-
natal rat sciatic nerves as previously described (Muir et al., 1989a). Loss
of normal growth control (immortalization) of secondary SCs was achieved
by continuous treatment for 100 d with 20 ng/ml cholera toxin (Sigma
Chemical Co., St. Louis, MO) as described (Muir et al., 1990a). RN22
and D6PZT Schwannoma cells (Bancal and Pfeiffer, 1987; Pfeiffer and
Wechsler, 1972) were cultured in DME containing 10% calfserum. Condi-
tioned media were collected from dense (3-5 x 106 cells/75 cm2) cultures
of SCs (SC CM) and RN22 Schwannoma (RN22 CM), thoroughly washed
with HBSS, and then incubated in serum-free DME for 24-48 h.
Schwann CellProliferationAssay andImmunostaining
forBromodeoxyuridine
Quiescent SC microcultures were established in polyornithine-treated 96-
well plates containing 14,000 cells/6-mm well in 100 Al of DME + 10%
calf serum as described (Muir et al., 19906). For some assays, SCs were
seededin polyornithine-coatedwellstreated with 50 Al ofa 2 pg/ml solution
of rat L2 yolk sac tumor laminin (prepared as described by Engvall et al.,
1983). SC/neuron co-cultures were established by adding 14,000 SCs and
2,000 embryonic day 8 ciliary ganglionic motor neurons to each microwell
as described (Muiret al., 1989a). Forroutineassays ofantiproliferative ac-
tivity on mitogen-stimulated SCs, microcultures were seeded in DME +
10% calf serum containing 20 ng/ml cholera toxin. Serially diluted test
samples were presented for 72 h and bromodeoxyuridine (BrdU) (Sigma
Chemical Co.) wasadded to a concentration of 10 AM during thefinal 24 h.
SC proliferation was assessed by direct cell counting and BrdU incorpora-
tion into DNA was measured by an ELISA performed on fixed monolayer
microcultures as previously described (Muir et al., 19906). Briefly, follow-
ing BrdU incorporation, the microcultures were fixed by 70% ethanol and
the DNA denatured by incubation with 2 M HCl for 10 min at 37°C. BrdU-
DNA was labeled using monoclonal anti-BrdU antibody (Dako-Potts
Corp., Santa Barbara, CA) (50 AI/well; 1 pg/ml) and bound antibody was
detected by peroxidase-conjugated rabbit anti-mouse IgG (Dako-Potts
Corp.) (50 pl/well; 2 pg/ml). The colorimetric substrates o-phenylenedia-
mine (0.05%) and H202 (0.02%) were added in 80 pl of 50 mM phos-
phate/citrate buffer at pH 5 and the reaction was terminated after 5-20 min
by adding 40A] of2 M sulfuric acid. The adsorbance was measured at 490
nmbya microplatereader (MR600; Dynatech Labs, Alexandria, VA) inter-
faced with a computer. Using cholera toxin-stimulated SCs, the titer ofeach
sample in antiproliferative units (APU)/ml was expressed as the sample di-
lution required to inhibit by 50% the maximal incorporation of BrdU into
DNA (BrdU-DNA immunoactivity). The percentage of cells with BrdU-
DNA wasdetermined by immunostaining as described above in the ELISA
except the insoluble chromagen diaminobenzedine-tetrahydrochloride was
used. Proliferation assays using immortalized SC and rat schwannoma cell
lines were performed as described above for SCs except that no mitogens
were added to the serum-supplemented medium.
NAPIsolation
An effective but low-yield purification scheme wasused to isolate the 55-kD
NAP by dissociation from a high molecular weight complex followed by
preparative gel electrophoresis as previously described (Muir et al.,
1990a). Alternatively, a NAP-enriched fraction was obtained by the follow-
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ing fractionationsequence and a step-by-step monitoring ofantiproliferative
activity using the BrdU-ELISA ofmitogen-stimulated SCs. Serum-free SC
or RN22 CM (1 liter) adjusted to pH 7.8 and passed over a DEAF column
(2 x 10 cm) resulted in a twofold increase in the total NAP activity in the
nonbinding fraction (probably because of the removal of a DEAF-binding
NAP inhibitor). The NAP sample was then applied to heparin-sepharose
and the active nonbinding fraction was concentrated 200-fold and equili-
brated with PBS by ultrafiltration using a 10-kD cut-off filter (Amicon
Corp., Danvers, MA) . The concentrate was submitted to CL4B (Pharmacia
Fine Chemicals, Piscataway, NJ) gel filtration performed on a 2.5 x 100
cm column equilibrated with PBS and the antiproliferative activity eluting
in one majorpeakwith a molecular mass corresponding to =55 kD was col-
lected and concentrated. Heparin-affinity chromatography was performed
on a 1.4 x 7 cm column equilibrated with 10 mM sodium phosphate buffer
(pH 7.2) containing 0.1 M NaCl. A heparin-binding fraction was eluted in
one step with 0.5 M NaCl in phosphate buffer. The preparation from serum-
free RN22 CM contained =50 Agtotal protein and 1,600 APU. The sample
contained =8 pg of NAP and thus was =15% NAP protein and was used
for many preliminary studies later to be repeated with the electrophoreti-
cally homogeneous preparation described previously.
ImmunoassaysforStromelysin
Fractions generated during isolation of the 55-kD NAP were examined for
stromelysinby enzyme-linked immunosorbentassay as described (Engvall,
1980). The anti-stromelysin mAbs used recognize both prostromelysin and
activated stromelysin and were a generous gift from Dr. Scott Wilhelm
(Miles Laboratories, West Haven, CT) . The NAP-enriched preparations
were examined by Western immunoblotting as previously described (Muir
et al., 19896).
Immunosequestration of stromelysin from NAP-enriched preparations
was performed to test ifantiproliferative activity resided inthis antigen. The
anti-stromelysin mAbs were mixed with protein A-Sepharose (Pharmacia
Fine Chemicals) in 0.5 M glycine buffer (pH 8.9) containing 3 M NaCl and
incubated for 1 h. The sepharose was collected by brief centrifugation,
washed, and then mixed with NAPenriched preparations. After a2-h incu-
bation, the material bound to the immuno-sepharose was removed by cen-
trifugation and the resulting supernatants were assayed for NAPactivity and
residual stromelysin immunoreactivity by ELISA. Similar immunoseques-
trationmethods using proteinA-Sepharose and mouse polyclonal antibodies
raised against the antiproliferative amino-terminal FN fragment were used
to identify the active component in the 30-kD fraction of SC CM.
Zymography
Substrates were cross-linked into the acrylamide/bis-acrylamide resolving
gels by adding 1 mg/ml solubilized alpha-casein. Samples were electropho-
resed under nonreducing conditions at 4°C according to Laemmli (1970).
The gels were washed 3 x 10 min with 2.5% Triton X-100 to remove SDS
and then washed with 50 mM Tris-HCI, pH 8.0. Protease digestion of the
cross-linked substrate progressed during incubation of the gel for 16-32 h
at 37°C in the same buffer containing 5 mM CaC12. As specified, the gels
were incubated in buffer containing the protease inhibitors 1, 10-phenan-
throline (10 mM), EDTA (10 mM), PMSF (0.5 mM), N-ethylmaleimide
(NEM) (10 mM), aprotinin (1 pg/ml), cystatin (1 pg/ml), or pepstatin (1 pg/
ml). Following incubations, the gels were fixed with 50% methanol/10%
acetic acid, stained with 0.2% Coomassie blue R250 and then destained in
a diluted fix solution.
SubstrateCleavage by the CM-derived SS-kDProtease
RN22 CM is an abundant source for isolating the 55-kD metalloprotease
(a latent enzyme) and this preparation could be activated by treatment with
4-aminophenylmercuric acetate (APMA) or trypsin and was most active in
the presence of Cal'. For analytical purposes the 55-kD metalloprotease
was incubated at various enzyme/substrate ratios for 48-72 hat 37°C (30°C
fortypeI Collagen) in 25 mM Tris-HCI, pH 8.0containing NaCl (100 mM),
CaCl2 (5 mM), APMA (1 mM), PMSF (0.5 mM), NEM (10 mM), and
aprotinin (1 pg/ml). The cleavage products were mixed with Laemmli sam-
ple buffer with and without ß-mercaptoethanol (5%) and analyzed on
5-15% acrylamide gels and then stained with Coomassieblue R250 in 50 %
methanol and 10% acetic acid. The substrates tested were FN (prepared as
described below), laminin (Bethesda Research Laboratories, Gaithersburg,
MD), native type I collagen (VitrogenCollagenCorp.), and native IV colla-
gen (Collaborative Research Inc., Bedford, MA).
178Fibronectin Degradation andIsolationof the
29-kDCAFF
Bovine and rat plasma FNs were isolated from citrated plasma (Pel Freez
Biologicals, Rogers, AR) by two cycles of gelatin-affinity chromatography
(Engvaf and Ruoslahti, 1977) using4M urea to elute boundFN. The eluted
fraction was concentrated by ultrafiltration using a 100ÁD cut-off filter
(Amicon Corp.) and the concentrate was submitted to CL4B gel filtration
and the peak fractions of =400-440 kD were collected . Ferritin (440 kD)
was used as a molecular mass standard for calibration . Unfragmented hu-
man plasma FN was prepared by submitting human plasma FN (New York
City Blood Center, New York, NY) to CL4B gel filtration .
To analyze the proteolytic fragments, 1 mg of purified FN was mixed
with =8 Wg ofthe55-kD metalloprotease preparation and incubated for72 h
at 37°C in 25 mM Tris-HCI, pH 7 .6 containing NaCl (100 mM), CaCIZ
(5 mM), APMA (1 mM), PMSF (0.5 mM), NEM (10 mM), and aprotinin
(1 p,g/ml) . For preparative yields of FN fragments, 25 mg of FN was
digested with 500 pg of porcine plasmin (Sigma Chemical Co.) for 20 h
at 37°C in 25mM Tris-HCI, pH 8.4 containing NaCl (100mM) and lysine
(10 mM) . Each digest was applied to the following sequence of 10 nil
columns (1.4 x 7 cm) connected in tandem: DEAE-cellulose (Whatman
Laboratory Products Inc., Clifton, NJ), gelatin-sepharose (Pharmacia Fine
Chemicals), and heparin-sepharose (Pharmacia Fine Chemicals) . The
columns were uncoupled and the bound materials were eluted from DEAE
with 0.5M NaCl, from gelatinwith 4M urea, and from heparin with 0.5M
NaCl . The elutes were concentrated by PM10 ultrafiltration (Centriprep ;
Amicon Corp.) and equilibrated with PBS . The heparin-binding, 0.5 M
NaCl eluted concentrate was found to be greatly enriched in antiprolifera-
tive activity and was further fractionated by S200 (superfine; Pharmacia
Fine Chemicals) gel filtration in PBS . All fractionations were performed at
4°C . The fractions were assayed for antiproliferative activity using SC
microcultures as described above and mostwere also analyzed on SDS gels .
The heparin-binding, antiproliferative activity eluting from gel filtration
corresponding to 29 kD was tested for an ability to bind actin using a
modification ofthe methods described by Keski-Oja and co-workers (1980) .
Amino acid analysis was performed on a Sequenator (Applied Biosystems,
Foster City, CA) .
Results
NAPCopurifies with aMetalloprotease Activity
We previously reported (Muir et al ., 1990x) that media con-
ditioned by rat SC cultures and by schwannoma cell lines
contained an identical antiproliferative activity which can
completely inhibit proliferation by mitogen-stimulated SCs .
Gel filtration of either CM resolved three distinct forms of
antiproliferative activity and a predominant 55-kD compo-
nent, termed NAP, was isolated and partially characterized .
NAP isolated fromCM exhibited several properties which
suggested it might contain proteolytic activity. For instance,
by removing the DEAE-binding material fromCM, the total
antiproliferative activity collected in the nonbinding fraction
was increased, suggesting an inhibitorwas removed . In addi-
tion, concentration oftheCM or activity-enriched fractions
caused further increases, perhaps resulting from activation
by proteases . This possibility was supported by the finding
that the antiproliferative activity of the 55-kD NAP was
increased by mild treatment with trypsin . In addition, inacti-
vation resulted from treatments with heat and disulfide-re-
ducing agents . Each of these observations is also consistent
with the speculation that the 55-kD NAP itself possesses
proteolytic activity. To test this idea, an electrophoretically
pure preparation ofNAP (Fig . 1 A, lane 1) was analyzed by
substrate-overlay gel electrophoresis (zymography) . The
results are shown in Fig. 1 A . A single zymographic band
with caseinolytic activity appeared with a relative molecular
mass of 55 kD (lane 2) . This proteolytic profile was elimi-
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Figure 1. Casein-degrading activity and anti-stromelysin im-
munoreactivity associated with the 55-kD NAP (A) A highly en-
riched preparation of the 55-kD NAP obtained from serum-free
RN22 CM was examined by nonreducing SDS-PAGE and protein
staining (lane 1) . On zymographic gels the 55-kD NAP contained
a 55-kD caseinolytic activity (lane 2) which was eliminated when
zymography was performed in the presence of the zinc chelator 1,
10-phenanthroline (lane 3) . The RN22 CM-derived NAP was ex-
amined for anti-stromelysin immunoreactivity by Western immu-
noblotting (lane 4) . Molecular weight designations represent the
migration positions ofBSA (67 kD) and ovalbumin (46W) on 12
acrylamide standard and zymographic gels and on Western blots .
(B) Crude serum-freeCM was collected after 2 d from dense cul-
tures of RN22 Schwannoma (lane 1) and isolated SCs (lane 2) and
then concentrated 300-fold by ultrafiltration (10-kD cut off) . The
concentrate (20 lcl) was run on 12% acrylamide mini-gels under
nonreducing conditions, electroblotted to nitrocellulose, and im-
munoperoxidase stained using monoclonal anti-stromelysin anti-
bodies as described in Materials and Methods . Molecular weight
designations represent the migration positions of BSA (67 kD),
ovalbumin (46 kD), and carbonic anhydrase (30 kD) .
nated when zymography was performed in the presence of
the metal chelator 1, 10-phenanthroline (lane 3), indicating
the NAP preparation contained a 55-kD metalloprotease .
Other protease inhibitors (i.e ., PMSF, NEM, aprotinin,
cystatin) did not diminish the protease band (results not
shown) .
NAPCopurifies with Stromelysin Immunoreactivity
The properties of the SC-derived 55-kD metalloprotease
closely paralleled those reported by Chin and co-workers
(1985) for stromelysin and the rat equivalent, transin(Umen-
ishi et al ., 1990) . Consequently, when fractions were as-
sayed for stromelysin immunoreactivity by ELISA, 55-kD
NAP activity and stromelysin immunoreactivity were found
to co-purify in each of our purification steps . Furthermore,
the 55-kD metalloprotease activity demonstrated by zymog-
raphy was shown by Western immunoblotting to co-migrate
179with a band stained by mAbs to stromelysin (Fig . 1 A, lane
4) . To determine the forms of stromelysin immunoreactivity
present in CMs, serum-free SC CM and RN22 CM were
concentrated and then examined by Western immunoblot-
ting . Immunostaining was performed using a cocktail of
specificmAbs which recognize prostromelysin and activated
stromelysin (Wilhelm et al ., 1991) . BothSC andRN22CMs
contained 55-58 kD (postromelysin) and 41-44 kD (acti-
vated stromelysin) forms, each appearing as band pairs . The
heterogeneity within each form is reportedly attributable to
partial glycosylations (Wilhelm et al ., 1987) . Interestingly,
while RN22CM and SC CM contained both forms, RN22
CM contained predominantly prostromelysin (and only a
trace of the lower mass form) while in SC CM the activated
form was much more abundant . These results, shown in
Fig . 1 B, lanes 1 and 2, suggest that SC cultures are capable
of converting prostromelysin to an active form whereas the
transformed RN22 cultures are not .
Attempts to determine the contribution of stromelysin to
the antiproliferative activity in CM samples were compli-
cated by the presence of more than one form of activity. Im-
munosequestration using anti-stromelysin antibodies bound
to protein A-Sepharose was only marginally effective at
reducing the total activity present in crude CM . Previous
results have shown three distinct forms of antiproliferative
activity in theCMs but immunosequestration performed on
enriched fractions of the high molecular mass (>1,000 kD)
and lower mass (=30kD) forms were ineffective at reducing
antiproliferative activities . However, for enriched prepara-
tions of55-kD NAP >60% of the antiproliferative activity
was removed by a single cycle immunosequestration . Addi-
tional cycles depleted more activity . Thus, it appeared likely
that the 1,000- and 30-kD forms were not immunologically
the same as the 55-kDNAP, but that the 55-kD antiprolifera-
tive factor is immunologically similar to stromelysin .
Substrate Specificityforthe
SC-derived Metalloprotease
Next, the 55-kD metalloprotease was tested for an ability to
degrade various extracellular matrix proteins including FN,
laminin, and native types I and IV collagens. After incuba-
tion with the 55-kD metalloprotease (andAPMA), only FN
appeared significantly degraded when the proteolytic sam-
ples were examined by SDS-gel electrophoresis performed
under nonreducing conditions . The results of FN degrada-
tion are shown in Fig . 2 (lane 2) . The large proteolytic frag-
ments had relative molecular masses of 140-160 kD and a
major cleavage product appeared with a mass of 29 kD . FN
degradation was attributed solely to metalloprotease activity
in that it was selectively abolished when digestion was at-
tempted in the presence of l, 10-phenanthroline (lane 1) .
These results indicated that, of the extracellular matrix pro-
teins tested, only FN was cleaved into distinct fragments.
However, further examination ofthe 55-kD protease-treated
samples on gels run under reducing conditions showed lami-
nin and typeIV collagen could be partially proteolysed while
type I collagen apparently was unaffected by the metal-
loprotease activity (results not shown) . The substrate tests
for the SC-derived, 55-kD metalloprotease gave results con-
sistent with those reported for rabbit fibroblast stromelysin
(Chin et al., 1984) .
The Journal of Cell Biology, Volume 116, 1992
Figure 2 . Proteolytic FN frag-
ments generated by the SC-de-
rived 55-kD metalloprotease. Bo-
vineplasmaFN (1 mg) was mixed
with =8 FAg ofthe 55-kD metallo-
protease and incubated for72 h at
37°C in25mM Tris-HO, pH 7.6,
containing NaCl (100 mM), CaC12
(5 mM), APMA (1 mM), PMSF
(0.5 mM), NEM (10 mM), and
aprotinin (1 )Ag/ml) . Incubation
was performed in the presence
(lane 1) or absence (lane 2) ofthe
metalloprotease inhibitor 1, 10-
phenanthroline. The samples were
electrophoreeed on 5-15% acryl-
amide gradient gels under nonre-
ducing conditions and then stained
with Coomassie blue . The digest
shownin lane 2 was applied totan-
demcolumns of DEAE-, gelatin-,
and heparin-sepharose . The frag-
ments which did notbind toDEAE
or gelatin but did bind to heparin
were eluted from the heparin col-
umn by 0.5M NaCl . The heparin-
binding, 0.5 M NaCl-eluted fraction
was concentrated by ultrafiltra-
tion (10-kD cut oft) and was fur-
ther fractionated by S200 (su-
perfine) gel filtration in PBS. The
fractions corresponding to =30
kD were pooled and examined by
SDS-PAGE (lane 3) as described above . The migration positions
of myosin (200 kD), phosphorylase b (92 kD), and carbonic anhy-
drase (30 kD) are indicated .
Proteolysis ofFN Generatesa Cryptic
AntiproliferativeActivity
The proteolytic mixture ofFN and 55-kD protease was then
fractionated by gel filtration and the resulting eluates were
assayed for antiproliferative activity. The results are shown
in Fig . 3 . Interestingly, antiproliferative activity was found
in two distinct peaks ; in addition to the 55-kD peak corre-
sponding to the added NAP (55 kD, prostromelysin) a peak
of new activity appeared in the elution profile at =30 kD,
which was enriched in a 29-kD FN fragment demonstrated
in Fig . 2 . If the 55-kD metalloprotease was converted (by
APMA) to an active form (M = 41-44 kD) during the pro-
teolytic incubations, this form was apparently labile or did
not express antiproliferative activity under the conditions of
theSC assay. The antiproliferative, 30-kD gel filtration frac-
tion did not show zymographic activity and was character-
ized further by affinity-chromatography steps aimed at
isolating fragments of FN with known binding properties .
The results are shown in Thble I . First, the antiproliferative
activity did not bind anion-exchange resin (atpH 8.0) or gela-
tin-sepharose . The activity-enriched, nonbinding fraction
was then applied to heparin-sepharose, which bound most
of the activity. The heparin-binding antiproliferative activity
was eluted by 0.5 M NaCl and appeared on SDS gels as a
nearly homogeneous band of29kD (Fig . 2, lane 3) . The 29-
kD protein was resistant to dansylation andEdman degrada-
1800
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Figure 3 . Antiproliferative activity in gel filtration fractions of a
proteolytic mixture ofthe 55-kD protease andFN . Bovine FN was
degraded by incubation with the 55-kD protease as described for
Fig . 2, lane 2 . The proteolytic mixture was concentrated and frac-
tionated by gel filtration and the eluted fractions were assayed for
antiproliferative activity, using cholera toxin-stimulated SCs as de-
scribed in Materials and Methods . Estimated molecular masses for
the two peaks ofantiproliferative activities are indicated by arrows .
Data represent the means ofduplicate determinations from two sep-
arate experiments .
tion (Table I), indicating that it had a modified (blocked)
amino terminus . Taken together, the properties of the 29-kD
fraction indicated that we had generated and isolated a 29-
kD, amino-terminal FN fragment (GAFF) with potent an-
tiproliferative activity for SCs. The cryptic 29-kD activity
was potent with an ED 5o = 60 nM and DNA synthesis by
mitogen-stimulated SCs could be completely inhibited by 10
pg/ml (see Fig . 7 D) . Nearly identical results were obtained
when either bovine (shown in lane 3), human, or rat FN
(results not shown) were treated with the 55-kD protease and
the digests fractionated as described above. We had previ-
ously observed that heparin does not bind the 55-kD NAP,
thus heparin-affinity can be used to separate the proteolytic
(NAP) and prcduct (GAFF) forms of antiproliferative ac-
tivity.
In a previous report (Muir et al., 1990a) the antiprolifera-
tive activity profile obtained by gel filtration of crude,
serum-containing SC CM also contained a peak at =30 kD.
To determine whether this form of activity might be attrib-
uted to a fragment ofFN (generated from serumFN) the 30-
kD SC CM-derived antiproliferative fraction (see Fig . 5,
Muir et al., 1990x) was submitted to the same fractionation
sequence used to isolate the antiproliferative bovine FN
fragment described above. As shown in Table I, the 30-kD
SC CM-derived activity did not bind DEAE or gelatin but
did bind heparin . In addition, the heparin-binding material
contained a component which appeared on SDS gels as a 29-
kD protein (Fig . 4, lane 1) which co-migrated with a band
on Western immunoblots stained by anti-FN polyclonal anti-
bodies (Fig . 4, lane 2) . In addition,>80% of the antiprolifer-
ative activity expressed by the 30-kD SC CM fraction was
removed by immunosequestration methods using antibodies
raised against the amino-terminal FN fragment . We con-
clude from these findings that SCCM contains a 29-kD an-
tiproliferative FN fragment with properties similar to that
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Three preparations containingFN fragments were found to express potent an-
tiproliferative activity for SCs. The proteolytic samples 55-kD protease +FN,
plasntin + FN, and 30-kDSCCMwere prepared as described in Materials and
Methods . Each sample contained proteolytic FN fragments and newly generat-
ed antiproliferative activity . The samples were adjusted to pH 8.0 and then
were applied to columns of DEAE-, gelatin-, heparin-, and actin-sepharose .
For each sample the heparin-binding antiproliferative fraction was further
purified by S200 gel filtration and examined by SDS-PAGE . All fractions were
assayed for antiproliferative activity using cholera toxin-stimulated SCs (scored
as expressing + or not expressing - activity) .
* The proteolytic samples inherently contained antiproliferative constituents
with known properties ; the APMA-activated, 55-kD protease does not bind
DEAE, gelatin, heparin, or actin and plasmin is not antiproliferative within the
concentration range used here .
generated by experimental proteolysis ofFN by the purified
SC-derived protease .
A PlasmingeneratedFNFragment with
Antiproliferative Activity
Our findings indicate that a SC protease with similarities to
stromelysin can degrade FN and generate a 29-kD hepa-
rin-binding fragment which expresses antiproliferative ac-
tivity. Efforts to obtain greater amounts of this proteolytic
fragment for detailed characterization were hampered by the
scarcity of purified SC-derived protease . However, we con-
sidered the possibility that we had isolated an antiprolifera-
tive FN fragment with molecular properties similar to those
reported for the 29-kD amino-terminal fragment of human
FN (McDonagh et al ., 1981 ; Homandberg et al ., 1985) .
Figure 4 . FN immunoreactivity in a heparin-
binding, 30-kD fraction obtained from se-
rum-supplemented SC CM . Serum-supple-
mented medium conditioned for 3 d by
quiescent SC cultures was applied to tan-
dem columns of DEAE-, gelatin-, and hep-
arin-sepharose . The material which did not
bind to DEAE or gelatin but did bind to
heparin was eluted from the heparin column
by 0.5 M NaCl and then was submitted to
gel filtration . The fractions corresponding
to =30 kD were pooled and examined by
SDS-PAGE and protein staining (lane 1)
and Western immunoblotting using poly-
clonal anti-FN antibodies (lane 2) . The
migration positions of carbonic anhydrase
(30 kD) and soybean trypsin inhibitor (21
kD) are indicated .
20 55 30 kD Table I . Antiproliferative Activity in Fractionsof
Proteolytic Fibronectin Fragments
E Antiproliferative activity in sample
y (attributable to the FN fragment)' w
.e
Property MAD protease+FN plasmin+FN 30-kD SC CM
N
10 DEAE binding - - -
m Gelatin binding - - -
Heparin binding + + +
a Actin binding + + n.d .
c N blocked + + n.d .
Q Molecular mass 29 kD 29 kD 29 kD1
￿
10
￿
100
Protein concentration (p.glml)
Figure S Proteolysis of FN by plasmin generates a cryptic an-
tiproliferative activity. Bovine FN and BSA were degraded with
plasmin as described in Materials and Methods and the proteolytic
mixtures were tested for antiproliferative activity using cholera
toxin-stimulated SCs . Intact FN was additive with the mitogenic
effects of cholera toxin . The mixture ofFN and plasmin, after 16 h
of incubation, expressed a potent antiproliferative activity capable
of completely inhibiting DNA synthesis . Plasmin, within the con-
centration range used to degrade FN did not inhibit SC prolifera-
tion and the proteolytic mixture of plasmin and BSA expressed no
antiproliferative activity. Data represent the means of quadruplicate
determinations from two separate experiments. (SD = <6%) .
Thus, plasmin was tested for an ability to generate an an-
tiproliferative FN fragment . Using a modification of the
procedures reported by McDonagh and co-workers (1981),
25 mg of bovineFN was degraded with plasmin and the pro-
teolytic mixture tested for antiproliferative activity using
cholera toxin-stimulated SCs . The results shown in Fig . 5
demonstrated that intactFN was additive with the mitogenic
effects of cholera toxin while plasmin, within the concentra-
tion range used to degrade FN, did not significantly affect
DNA synthesis . However, the mixture of FN and plasmin,
after 16 h of incubation, expressed a potent antiproliferative
activity capable of completely inhibiting DNA synthesis by
SCs . To determine ifthe activity was attributed to an amino-
terminal FN fragment, the digest (Fig . 6, lane 1) was passed
in tandem over DEAE-, gelatin-, and heparin-sepharose
columns . The heparin-binding material was eluted with 0.5M
NaCl and then submitted to gel filtration . The resulting frac-
tions were assayed for antiproliferative activity (see Table I)
and a major peak of activity was collected from gel filtration
corresponding to =30 kD. This highly enriched fraction ap-
peared on SDS gels as a single band (or sometimes as a band
pair) with 27-29 kD (Fig . 6, lane 2) . This sample was resis-
tant to dansylation and direct Edman degradation, thus we
concluded it had a blocked amino terminus and cor-
responded to the amino-terminal, 29-kD FN fragment de-
scribed by McDonagh and co-workers (1981) . From 25 mg
of intact FN N2 mg of this fragment was isolated . The
specific activity of thisFN fragment preparation was gener-
ally found to be between 200-400 nM (see below) although
the activity was somewhat variable and labile in solution .
Furthermore, the relative molecular mass on SDS gels also
appeared to change with time in storage from a 29- to a 27-
kD form and sometimes an apparent intermediate was seen
(Fig . 6, lane 3) . It seemed that an active29-kD form of the
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FN only
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Figure 6. Proteolytic FN frag-
ments generated by plasmin .
Bovine plasma FN (25 mg)
was digested with 500 ug of
porcine plasmin for 20 h at
37°C in 25 mM Tris-HCI, pH
8.4 containing NaCl (100mM)
and lysine (10mM) . The digest
(lane1) wasapplied to gelatin-,
tandem columns of DEAE-,
and heparin-sepharose . The
DEAE and gelatin non-bind-
ingFN fragments thatbound to
heparin were eluted from the
heparin column with 0.5 M
NaCl . The eluted fraction was
concentrated by PM10 ultra-
filtration and then was submit-
ted to S200 (superfine) gel
filtration . The fraction corre-
sponding to =30 kD was ex-
amined by SDS-PAGE imme-
diately (lane 2) or after being
stored in solution for 7 d at
4°C (lane 3) . Samples were
run under non-reducing con-
ditions on 5-15% acrylamide
gels which were then stained
with Coomassie blue . The mi-
gration positions of myosin
(200 kD), phosphorylase b
(92 kD), and carbonic anhy-
drase (30 kD) are indicated .
FN fragment would convert to a more compact configuration
which greatly reduced its antiproliferative activity. The na-
ture of this conversion is obscure and will require a more
detailed examination . In comparison, the 29-kD fragment
generated by the SC-derived metalloprotease was considera-
bly more stable and retained activity for weeks in solution .
The plasmin-generated fragment appeared similar to that
generated by the SC-derived protease in that they both : (a)
did not bind DEAE or gelatin ; (b) had a moderately high
affinity for heparin ; (c) coeluted from gel filtration ; (d) co-
migrated on SDS gels ; and (e) expressed potent antiprolifer-
ative activity for SCs . Nearly identical results were obtained
when either bovine (shown in Fig . 6), human, or rat FN
(results not shown) were treated with plasmin and the digests
fractionated as described above . These findings indicate that
a plasmin-generated, 27-29-kD, heparin-binding FN frag-
ment possessed a potent, albeit labile, antiproliferative activ-
ity for SCs .
While the isolation and characterization of the 29-kD
amino-terminal FN fragment generated by plasmin are well
documented, the properties of our preparation were further
examined to confirm this designation for the antiproliferative
activity. Additional results are shown in Table 1 . It is known
that the heparin-binding, amino-terminal 29-kD fragment
also binds actin and our preparations shared this property.
In addition, no sequence information was obtained by direct
Edman degradation and the fragment was resistant to dansy-
lation . Analysis of amino acid composition gave results (not
shown) consistent with published findings (McDonagh etFigure 7. Comparisonof NAP
and CAFF activities for SC
treated with various mitogens
and for SC lines. Subconflu-
ent microcultures ofrat sciatic
nerve SCs (14,000 cells/6-mm-
diam well) were grown with
100 j1 DME containing 10%
calf serumwith one ofthe fol-
lowing mitogens: soluble chol-
era toxin(20 ng/ml), polyorni-
thine-treated wellscoatedwith
rat laminin (50 I,1/well, 2 pg/
ml), or co-culture with cil-
iary ganglionicneurons (2,000
neurons/well). These mitogen-
stimulated SCs were treated
for 72 h with serial dilutions
of the (A) 55-kD NAP or (B)
GAFF (29-kD amino-terminal
o
￿
FN fragment generated by the
55-kDprotease). Immortalized
SC and two schwannoma cell
(RN22 and D6P2T lines) cul-
tures were grown in DME
containing 10% calf serum
and treated with the (C) 55
^^q
￿
kD NAP or (D) CAFF as de-
0
￿
.1
￿
1
￿
10
￿
100
￿
scribed above. Proliferation
CAFE (gg/ml)
￿
was assessed by addition of
BrdU (10 AM) to the media
during the final 24 h of the 72 h treatmentsand immunoassays of BrdU incorporation into DNA were performed as described in Materials
and Methods. Values for each condition were expressed as the percentage of maximal (BrdU)-DNA immunoactivity for cultures without
NAP or CAFF treatment. Data represent the means ofquadruplicate determinations from four separate experiments. (SD = <10 %, except
for A, neurons SD = < 12% and B, neurons SD = <15 %) .
NAP (ng/ml)
-~ CTx
Laminin
--t- Neurons
-+- SC+CTx
-"
￿
SC line
-~ RN22
D6P2T
Comparison ofNAP and CAFFActivities
al., 1981; Garcia-Pardo et al., 1983). Taken together, these
results indicate that a plasmin-generated, amino-terminal
fragment of FN has properties very similar to the antipro-
liferative FN fragment generated by the SC-derived 55-kD
protease and also to that found in SC CM.
In our earlier study (Muir et al., 1990a) both SC CM and
the 55-kD NAP inhibited proliferation by SCs stimulated
with various mitogens and with co-cultured regenerating
neurons. While the inhibition of SCs could be complete,
proliferation by immortalized SCs and schwannoma cell
lines was largely uninhibited (10-20%) by the antiprolifera-
tive activity. To test the hypothesis that NAP activity was
related to the production of a proteolytic FN fragment, we
first examined whether the activity of the 29-kD CAFF and
the 55-kD NAP shared the above mentioned characteristics.
The results are shown in Fig. 7. Similar to those obtained for
NAP activity (Fig. 7 A), the plots of CAFF antiproliferative
activity (Fig. 7 B) were superimposable (when expressed as
percent inhibition) for SCs treated with different mitogens.
In addition to finding that each activity could completely in-
hibitthe proliferation ofmitogen-stimulated SCs, both NAP
(Fig. 7 C) and CAFF (Fig. 7 D) only partially inhibited im-
mortalized SCs and schwannoma cell lines. These similari-
ties support the idea that NAP and CAFF activities inhibit
SC proliferation through the same pathway.
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Discussion
Large-yield cultures ofhighly purified SC can be established
which retain many of the characteristics of SCs in vivo, in-
cluding the abilities to proliferate and differentiate in associ-
ation with neurons (Porter et al ., 1986). During peripheral
nerve development and regeneration, SCs attach to neuronal
axons and proliferate in response to a neuronal cell surface
mitogen and then differentiate after retiring from the mitotic
cycle. The number ofSCs in differentiated nerve is generally
stable even though the neuronal mitogen appears to be pres-
ent since it can be extracted from axons associated with
quiescent SCs (Salzer et al ., 1980) . Some, if not all, SCs in
differentiated nerve retain an ability to proliferate in re-
sponse to nervetrauma or when cultured with mitogens such
as axolemmal fragments. Taken together, these observations
suggest that SC homeostasis probably involves a strong in-
hibitory component which maintains SC quiescence in the
presence of potentially mitogenic stimuli, including contact
with axons.
SC proliferation appears to be under negative autocrine
control . Medium conditioned by SC cultures contains potent
antiproliferative activity which can account for the quiescent
stateof SCs even in the presence of apparent serum and auto-
crine mitogens. From CM we have isolated a 55-kD an-
tiproliferative component capable of completely inhibiting
SC proliferation in response to potent mitogens including
regenerating axons. Results ofthe present study show the 55-
183kD NAP to possess metalloprotease activity. The SC-
derived metalloprotease exhibited biochemical, proteolytic,
and immunological properties similar to those reported for
stromelysin isolated from other sources (Chin et al., 1985 ;
Umenishi et al., 1990). In addition, our SCs were found by
PCR techniques to express stromelysin mRNA (personal
communication; Dr. Zena Werb, University of California,
San Francisco, CA) . These findings suggested that the 55-kD
antiproliferative factor isolated from SC CM was indeed
stromelysin and directed testing showed that NAP activity
was selectively depleted by anti-stromelysin antibodies.
Our results raised the possibility that autocrine control of
SC proliferation involved a cascade of proteolytic activities.
For most of our initial studies we used RN22 Schwannoma
cultures as a source of CM and characterized NAP as a 55-
kD metalloprotease. The predominant form of stromelysin
inununoreactivity found in RN22 CM corresponds to the la-
tent, 55-kD form of stromelysin indicating that activation of
the metalloprotease by the schwannoma cultures is ineffi-
cient. The 55-kD proform was activated by APMA and pre-
sumably by components produced by SCs in the test cultures.
The latter presumption was verified by the finding that SC
CM contained predominantly the 44-kD activated form of
stromelysin. In retrospect, RN22 CM was a favorable source
of NAP-metalloprotease activity since the proform is more
stable during fractionations to the extent that a 44-kD form
of antiproliferative activity was not detected following frac-
tionations. The proform ofstromelysin was presumably acti-
vated by a second SC-derived proteolytic activity which is
not found in the schwannoma cultures. It is interesting that
SC cultures produce extracellular plasminogen activator
(Kalderon, 1984a) and the plasmin-generating system has
been implicated in autocrine control of proliferation and
migration. Both tissue-type and urokinase-type plasminogen
activators are produced by SC isolated from neonatal rat
sciatic nerve (Alvarez-Buylla and Valinsky, 1985). Interest-
ingly, the amount of the tissue-type form decreased with in-
creasing time in culture while the production of the
urokinase-type form was constitutive (Krystosek et al.,
1988) . Furthermore, plasmin has been reported to catalyze
the first step in activation of stromelysin and this activation
occurs through a urokinase-type plasminogen activator-
dependent pathway (Goldberg et al., 1990). Evidently, it is
possible that activation of stromelysin by SC cultures can oc-
cur through a plasminogen activator/plasmin-dependent
pathway. Even though further study is required to determine
any role of the plasmin-generating system in the negative
control of SC proliferation involving stromelysin, it has been
well established that this system is involved in the regulation
of neuron-glia interactions (Kalderon, 1984b). In develop-
ing peripheral nerve, SCs first proliferate in response to con-
tact with a mitogenic signal on neuronal axons and then exit
the mitotic cycle and differentiate in close association with
axons. We speculate that the mitogenic signal presented by
neurons might modulate the proteolytic cascade by releasing
a protease inhibitor or by influencing SCs to decrease the
production or activation of the proenzyme.
Like stromelysin, the SC-derived, 55-kD metalloprotease
cleaved FN and generated a predominant 29-kD fragment
(cf., Fig. 2) . Accordingly, we hypothesized that instead of
acting on the cell directly, the metalloprotease cleaves FN
and generates a cryptic antiproliferative activity which main-
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tains SC quiescence. Several observations suggest that pro-
teolysis of FN might contribute to the inhibition of SC
proliferation by NAP. First, the 29-kD amino-terminal pro-
teolytic fragment of FN possessed antiproliferative activity
for SC in the nanomolar range. Second, FN is abundant in
the serum added to SC culture medium and is also reportedly
secreted by SCs (Cornbrooks et al ., 1983). Third, SC CM
(containing serum) contained a 29-kD FN fragment with an-
tiproliferative activity.
Homandberg and co-workers (1986) have isolated and se-
quenced a 29-kD amino-terminal FN fragment which in-
hibits the in vitro proliferation of bovine aortic endothelial
cells and they have made progress toward identifying the
peptide sequence responsible for the antiproliferative activ-
ity (Homandberg et al., 1989). Using published procedures
for obtaining well-characterized proteolytic FN fragments,
we confirmed that the 29-kD amino-terminal fragment
generated by other proteases also possesses antiproliferative
activity for SCs. However, the antiproliferative fragment
generated by the 55-kD metalloprotease was considerably
more stable and probably more potent. A more detailed
study of the amino acid sequences of these proteolytic prepa-
rations is required to determine the potential differences in
the cleavage sites addressed by these proteases.
In the above studies we generated and assayed a variety of
FN fragments and foundthat only the 29-kD amino-terminal
fragment (GAFF) expressed potent antiproliferative activity
capable of completely inhibiting proliferation by mitogen-
stimulated SCs. Since intact FN increases SC proliferation
(Muir et al., 1989a; BaronVan Evercooren et al., 1982), it
follows that the antiproliferative activity ofthe 29-kD amino-
terminal region of the FN molecule is cryptic and requires
proteolytic activation before it inhibits proliferation. Follow-
ing proteolysis, the amino-terminal fragment becomes sepa-
rated from the RGD cell binding domain of FN. To test
directly whetherthe inhibitory activity ofCAFF couldbe an-
tagonized by native FN or RGD-containing FN fragments,
mitogen-stimulated SCs were treated with a maximally in-
hibitory concentration of CAFF in the presence of cell-
binding FN polypeptides. The presence of these FN poly-
peptides did not diminish the inhibitory activity of CAFF
(unpublished observations) suggesting that the antiprolifera-
tive effect on SCs is not mediated by conventional FN recep-
tors. Similarly, Homandberg and co-workers (1985) reported
that inhibition of endothelial cell proliferation by an amino-
terminal FN fragment was not antagonized by native FN.
In support ofthe hypothesis that inhibition ofSC prolifera-
tion by the 55-kD metalloprotease and the 29-kD FN frag-
ment occurs through the same pathway, we demonstrated that
both proteins expressed parallel activities for normal and
transformed SCs. Previously we reported (Muir et al.,
1990a) inhibition by the 55-kD NAP to be independent of
the type of mitogen used to stimulate SC proliferation, and,
using the same mitogens, this observation held true for inhi-
bition by CAFF. Also, compared to normal SCs, immortal-
ized and transformed SC lines are nearly unresponsive to the
inhibitory affects ofNAP Similarly, proliferation by immor-
talized SC and two schwannoma cell lines was not inhibited
substantially by the antiproliferative FN fragment. It is in-
teresting to speculate aboutthe possible connectionbetween
the lack of response by transformed SCs and the lack ofacti-
vated stromelysin found in their CM.
184SC mitogens such as cholera toxin that increase intracellu-
lar cAMP require the presence of serum or growth factors
(Ridley, 1990; David, 1990; Eccleston, 1989) and elevated
cAMP might cause an up-regulation of growth factor recep-
tors on SCs (Weinmaster and Lemke, 1990). Moreover,
mitogenic axonal membranes have been reported to elevate
cAMP (Ratner, 1984; see Meador-Woodruff et al., 1984 for
contrary report) and recent speculation has raised the idea
that the effects of axon-associated signals in SC development
are to a significant extent mediated by elevation of cAMP lev-
els in SCs (Jessen and Mirsky, 1991) . Down-regulation of
growth factor receptors might be a mechanism for antipro-
liferative control in the presence of diverse SC mitogens, in-
cluding the axonal mitogen . Our results are compatible with
the presumption that, although quiescent SCs might down-
regulate growth factor receptors, they actively express re-
ceptors that mediate an autocrine antiproliferative activity
(by binding the antiproliferative FN fragment) . If these two
opposing classes of receptors are reciprocally regulated,
agents that elevate CAMP and induce receptors for growth
promoters might coordinately decrease receptors for growth
inhibitors. Consistent with this contention, we have estab-
lished a line of SCs immortalized by prolonged treatment
with cholera toxin. In addition, this SC line requires serum
for continued proliferation in the absence of cholera toxin.
Itappears likely that, as part ofa transformed phenotype, im-
mortalized SCs and schwannoma cell lines constitutively
overexpress growth factor receptors while both are unre-
sponsive to the antiproliferative activitiesthey secrete. It will
be important to test further the implication that under ex-
pression of receptors for a cryptic FN fragment might ex-
plain how transformed SCs have escaped negative autocrine
growth control .
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